Spinal Tech

Biomet Acquires Massachusetts’ Cytosol Laboratories

Biomet, a Warsaw, Ind.-based musculoskeletal medical products manufacturer, acquired the assets of Cytosol Laboratories, a Braintree, Mass.-based small volume anticoagulants producer, according to a Biomet news release.

Laura Dyrda

Monday, July 19th, 2010

Cytosol currently has three proprietary products with new drug application approvals: TriCitrasol, noClot-50 and Rejuvesol.

Read the Biomet news release.

Read other coverage on Biomet.

-Biomet’s Indiana Facility to Expand

-Biomet Sports Medicine Mobile Learning Center to Provide Product Demonstration and Education

-Biomet Announces 4Q FY 2010 Financial Results

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

The patient-as-consumer era: How to deliver retail-grade experiences in healthcare

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's